Get started
Author

Károly Horvát-Karajz

Observed names: K Horvát-Karajz, K. Horvat-Karajz, K. Horvát-Karajz, Karoly Horvat-Karajz, Károly Horvát‐Karajz
ORCID: 0009-0000-4446-397X
Observed ORCID: 0009-0000-4446-397X
OpenAlex ID: A5081121405
In vitro effect of carboplatin, cytarabine, paclitaxel, vincristine, and low‐power laser irradiation on murine mesenchymal stem cells
2009 · Károly Horvát‐Karajz, Zsuzsanna Balogh, et al. · Lasers in Surgery and Medicine · 59
A sensitive microplate-based continuous-monitoring (kinetic) assay for serum neutral endopeptidase (EC 3.4.24.11) activity
1996 · L. Selmeci, I. Szokodi, et al. · Clinica Chimica Acta · 11
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy
2019 · Zsuzsanna Kahan, Daniela Grecea, et al. · BMC Cancer · 9
PDF
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis
2025 · Lothar Seefried, Serge Ferrari, et al. · Osteoporosis International · 5
PDF
Efficacy and safety of RGB-02, a proposed biosimilar pegfilgrastim to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind, phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving docetaxel/doxorubicin
2017 · K. Horvat-Karajz, D. Grecea, et al. · Annals of Oncology · 3
PDF
Abs0335 Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity Evaluation of the Proposed Tocilizumab Biosimilar Rgb-19 Subcutaneously Administered to Healthy Male Participants: a Phase 1, Randomised, Single-dose Cross-over Study
2025 · P. Emery, E. Choy, et al. · Annals of the Rheumatic Diseases · 2
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase
2026 · Serge Ferrari, Lothar Seefried, et al. · Osteoporosis International · 1
PDF
A Randomized Phase 1 Study Comparing the PK , PD , Safety, and Immunogenicity of Proposed Biosimilar RGB ‐14‐X and Denosumab in Healthy Adult Males
2026 · Emmanuel Biver, Jean‐Jacques Body, et al. · Clinical and Translational Science · 1
PDF
RGB-02 (Biosimilar Pegfilgrastim) In The Treatment Of Chemotherapy-Induced Neutropenia
2019 · Dóra Sántha, András Illés, et al. · Future Oncology · 1
PDF
Safe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials
2018 · A. Illes, L. Perjesi, et al. · Annals of Oncology · 1
[Modern diagnosis and treatment of pancreatic cancer--from the viewpoint of the internist].
2005 · Károly Horvát-Karajz · PubMed · 1
[Systemic chemotherapy of liver cancer and patient follow-up].
2004 · Károly Horvát-Karajz, Lídia Sréter · PubMed · 1
[Activity of neutral endopeptidase in serum of patients with primary biliary cirrhosis].
2000 · K Horvát-Karajz, A Csepregi, et al. · PubMed · 1
Corrigendum to ‘Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study’ [EULAR Rheumatology Open 1 (2025) 282–290]
2026 · Tomoko Hasunuma, Paul Emery, et al. · EULAR Rheumatology Open
Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study
2026 · Hiroaki Matsuno, Ernest Choy, et al. · EULAR Rheumatology Open
PDF
Clinical development programme of RGB-19 as a biosimilar to tocilizumab
2026 · Ernest Choy, Gordana Dancer, et al. · Video Journal of Biomedicine
PDF
2910P A multicentre, randomised, double blind, phase I study comparing the pharmacokinetics and pharmacodynamics of proposed biosimilar RGB-14-X and reference denosumab in healthy adult males
2025 · E. Biver, J-J. Body, et al. · Annals of Oncology
Pos0659 Efficacy, Safety and Immunogenicity of the Proposed Tocilizumab Biosimilar Rgb-19, Intravenously Administered to Participants With Active Rheumatoid Arthritis: Week 24 Data From a Phase 3 Study
2025 · E. Choy, P. Emery, et al. · Annals of the Rheumatic Diseases
P137 Non-Hodgkin lymphoma in a transplanted kidney
2007 · K. Horvát-Karajz, É. Toronyi, et al. · Blood Reviews
[Pancreatic cancer].
2006 · Károly Horvát-Karajz · PubMed
P362 Azathioprine and methylprednisolone for the treatment of idiopathic granulomatous hepatitis
2003 · K. Horvat-Karajz, L. Floro, et al. · European Journal of Internal Medicine
Immunomagnetic detection and characterisation of circulating tumour cells and cell clusters in patients with colorectal cancer
2001 · L. Floro, B. Molnar, et al. · European Journal of Cancer
Serum neutral endopeptidase activity in patients with primary biliary cirrhosis
1998 · K. Horvát-Karajz, F. Szalay, et al. · Gastroenterology
PDF
Works count: 24
Citation count: 97
H-index: 4
I10-index: 2
Year
Topic
Type